We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 171

New Government legislation programme: industry & sector specific breakdown- SpringSummer 2015

  • William Fry
  • -
  • Ireland
  • -
  • January 16 2015

The Irish Government has published its legislation programme for the SpringSummer 2015 parliamentary session. There are 32 Bills which are currently

Apple HealthKit - the rise of the mobile health app and its data protection implications

  • McCann FitzGerald
  • -
  • Ireland
  • -
  • December 22 2014

With the launch of iOS 8 Apple included a new developer framework called HealthKit. The premise of HealthKit is simple: an operating system wide

Privacy & cybersecurity update, issue 3 - October, 2014

  • Jones Day
  • -
  • Australia, Brazil, Canada, Chile, China, European Union, France, Germany, Hong Kong, Ireland, Italy, Japan, Mexico, Netherlands, New Zealand, Russia, Taiwan, USA
  • -
  • October 15 2014

On August 1, the Federal Trade Commission ("FTC") issued a report on mobile shopping applications. In it, the FTC found that such apps often fail to

Clinical trial agreements: Five key concepts

  • LK Shields
  • -
  • Ireland
  • -
  • January 24 2013

Clinical trials play a pivotal role in the development of market-safe pharmaceuticals and medical devices and, needless to say, sit within an

A warning to disciplinary panels of regulatory bodies: the impact of “Bloodgate” goes beyond sport

  • A&L Goodbody
  • -
  • Ireland, United Kingdom
  • -
  • August 15 2011

Many people will remember the infamous fake blood incident that tarnished the sport of rugby union which became known as “Bloodgate”

Interim injunctions and the pharmaceutical industry in Ireland

  • Matheson
  • -
  • Ireland
  • -
  • February 4 2011

The launch of a generic product onto the marketplace in competition with a patented pharmaceutical product can have devastating effects on an originator company's market position and pricing strategy

Mental health, taking of blood samples without patient consent

  • Matheson
  • -
  • Ireland
  • -
  • February 1 2012

Mr Justice MacMenamin in his judgement dated 26 July 2011, held that the taking of blood samples by doctors treating a woman suffering from severe mental illness was lawful, despite her failure to give consent

Liability at common law of a parent company to an employee of its subsidiary

  • A&L Goodbody
  • -
  • Ireland, United Kingdom
  • -
  • September 20 2011

In a recent UK High Court case a parent company was held to owe a duty of care to an employee of a subsidiary company, where the employee had been exposed to asbestos and subsequently suffered asbestosis, in circumstances where the subsidiary company was no longer in existence

English Patents Court revisits the clearing the way principle in preliminary injunction applications

  • Matheson
  • -
  • Ireland, United Kingdom
  • -
  • March 15 2011

In the recent English case of Cephalon Inc. and others v Orchid Europe Ltd and others (2010), Mr Justice Floyd of the Patents Court revisited the “clearing the way” principle in cases where there is a threatened launch of a generic product onto the marketplace

Vicarious liability extended?

  • William Fry
  • -
  • Ireland
  • -
  • November 7 2014

The High Court recently decided that the Health Service Executive (HSE) owed a duty of care to a property owner whose property was damaged when the